근적외선 이미징 시장 : 예측(2026-2031년)

The near infrared imaging market is set to grow at a 12.36% CAGR, reaching USD 2910.381 million in 2031 from USD 1,446.540 million in 2025.

The near infrared imaging market is experiencing rapid growth driven by technological advantages, expanding clinical applications, and increasing disease burden. This non-destructive imaging technology, which creates detailed images using near-infrared wavelengths, is gaining prominence across multiple medical specialties due to its unique capabilities and patient safety profile. The convergence of rising chronic disease prevalence, particularly cancer, alongside ongoing research and development in fluorescent agents, is propelling market expansion.

Primary Market Drivers

Intrinsic Technological Benefits

Near infrared imaging offers numerous advantages that constitute a significant growth driver. The technology provides a non-ionizing imaging modality that substantially enhances patient safety compared to alternative techniques such as X-ray or CT scans, eliminating radiation exposure concerns. This safety profile enables repeated imaging as clinically necessary without cumulative radiation risks.

The technology facilitates early disease detection, particularly for conditions like cancer, enabling timely intervention and improved patient outcomes. The non-invasive nature of near infrared imaging reduces patient discomfort, lowers complication risks, and supports better patient compliance with monitoring protocols. These combined advantages make NIR imaging increasingly attractive for clinicians seeking safer, more patient-friendly diagnostic and monitoring solutions.

Chronic Disease Prevalence

The increasing prevalence of chronic diseases-including cancer, cardiovascular conditions, and neurological disorders-has driven substantial demand for advanced imaging technologies like near infrared imaging to support enhanced disease management and treatment planning. The chronic disease burden is considerable: 81 million Americans had multiple chronic ailments in 2020, demonstrating high prevalence. In India, chronic diseases account for more than 50% of all deaths, while diabetes affects 77 million Indians currently, with projections indicating growth to 134 million by 2045. These statistics underscore the expanding patient populations requiring advanced diagnostic and monitoring capabilities that NIR imaging can provide.

Oncology Applications

Near infrared imaging technology has found extensive applications in oncology, including tumor localization, surgical guidance, and treatment response monitoring. NIR fluorescent agents can target specific cancer cells, providing real-time intraoperative feedback and aiding complete tumor removal. The expanding cancer burden globally amplifies demand for these capabilities: cancer represents the leading cause of death worldwide, accounting for almost 10 million deaths in 2020, while approximately 400,000 children develop cancer annually. These figures highlight the critical need for advanced imaging technologies that improve surgical precision and treatment outcomes.

Minimally Invasive Surgery and Remote Imaging

Near infrared imaging's non-invasive nature and portability make it well-suited for point-of-care and remote imaging applications, aligning with healthcare's broader shift toward minimally invasive approaches. In 2020, 13.2 million minimally invasive cosmetic procedures were conducted out of 15.6 million total cosmetic procedures, demonstrating the scale of minimally invasive surgical adoption. During the pandemic, approximately 95% of U.S. healthcare centers offered telehealth services, highlighting the healthcare system's capacity for remote care delivery. Market leaders' development of portable imaging devices further enhances accessibility for remote imaging solutions, expanding the technology's potential applications.

Market Opportunities

The growing chronic disease prevalence combined with rising elderly populations provides opportunities for market players to enhance technology and patient experience. Development and approval of novel NIR fluorescent agents creates new opportunities for targeted imaging and diagnostics, expanding the technology's clinical utility and market potential.

Market Constraints

Despite robust growth prospects, the near infrared imaging market faces technical and operational challenges. Near-infrared light demonstrates limited penetration depth in biological tissues compared to alternative modalities like ultrasound or MRI. This limitation restricts visualization of deeper anatomical structures, particularly in patients with increased tissue thickness or elevated body mass index.

Additionally, the absence of standardized protocols and imaging procedures for NIR imaging can hinder seamless integration into existing healthcare practices and imaging workflows. Establishing widely accepted standards remains an important developmental priority for market maturation.

Regional Dynamics and Developments

North America is positioned to hold significant market share during the forecast period, supported by rising cancer cases, increased healthcare expenditure, government support, and early adoption of technological advancements. In 2020, 1,603,844 new cancer cases were reported in the United States, with 602,347 cancer-related deaths recorded. The presence of major market leaders including Infiniti Electro-Optics, OmniVision, and Karl Storz further accelerates regional market development.

Recent developments underscore ongoing innovation. In August 2022, Shimadzu developed the LuminousQuester NI system combining adaptable camera hardware with user-friendly software to advance drug discovery research. In March 2022, Swift Medical launched Swift Ray 1, a hyperspectral imaging device that wirelessly attaches to smartphones, providing comprehensive clinical data for skin and wound condition monitoring and treatment.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Near Infrared Imaging Market Segmentation

• By Product
• Near Infrared Flourescence Imaging Systems
• Near Infrared Flourescence & Bioluminescence Imaging Systems
• By Application
• Pre-Medical Imaging
• Medical Imaging
• Clinical Imaging
• By End-User
• Hospitals & Clinics
• Research Laboratories
• Others
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEAR INFRARED IMAGING MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Near Infrared Flourescence Imaging Systems
• 5.3. Near Infrared Flourescence & Bioluminescence Imaging Systems

6. NEAR INFRARED IMAGING MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Pre-Medical Imaging
• 6.3. Medical Imaging
• 6.4. Clinical Imaging

7. NEAR INFRARED IMAGING MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals & Clinics
• 7.3. Research Laboratories
• 7.4. Others

8. NEAR INFRARED IMAGING MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Near Infrared Imaging
• 10.2. Artinis Medical Systems
• 10.3. Ecole Polytenique Federale de Lausanne
• 10.4. OmniVision
• 10.5. Kaer Labs
• 10.6. Karl Storz
• 10.7. Rocket Reach
• 10.8. ThorLabs
• 10.9. Texas Instruments
• 10.10. Olympus Life Science

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations